You are here

Europe -
Assessing allergenicity of GM plants: new EFSA guidance provides advice

EFSA has published supplementary guidance on allergenicity to further strengthen risk assessment of genetically modified (GM) plants. The document considers new scientific and regulatory developments, complementing recommendations in existing guidance and regulations. What are the key points? The new guidance relates to three particular areas. Non-IgE-mediated adverse immune reactions to food comprise a large group of diseases, mostly occurring during childhood. Celiac disease is currently the best characterised of these diseases and therefore the only condition of this type covered by the...

Europe -
Efsa : la moitié des scientifiques seraient en situation de conflit d’intérêts

Une association révèle les conflits d’intérêts que certains scientifiques pourraient entretenir avec de grandes entreprises au sein de l’Efsa, l’Autorité européenne de sécurité des aliments. Selon un rapport de l’ONG Corporate Europe Observatory (CEO), près de la moitié des scientifiques de l’Autorité européenne de sécurité des aliments seraient en situation de conflit d’intérêts. “ Nous considérons que sur les 211 experts de l’EFSA aujourd’hui, 46 % sont dans une situation de conflit d’intérêts financier direct et/ou indirect. [...] Or, on sait qu’avoir un lien financier avec une entreprise...

Europe -
EFSA confirms safe levels for nitrites and nitrates added to food

Existing safe levels for nitrites and nitrates intentionally added to meat and other foods are sufficiently protective for consumers, EFSA has concluded after re-evaluating their safety. Consumer exposure to nitrites and nitrates as food additives is within safe levels for all population groups, except for a slight exceedance in children whose diet is high in foods containing these additives. However, if all dietary sources of nitrites and nitrates are considered, the safe levels (ADIs) may be exceeded for all age groups. Sodium and potassium salts of nitrite and nitrate (E 249-252) are...

Europe -
Le Bisphénol A reconnu comme perturbateur endocrinien

Sur proposition française, l'Agence européenne des produits chimiques vient de classer le bisphénol A parmi les "substances extrêmement préoccupantes". Une victoire pour les associations qui alertent et sensibilisent sur les dangers des perturbateurs endocriniens. L 'Agence européenne des produits chimiques (European Chemicals Agency, ECHA) a enfin reconnu les propriétés de perturbation endocrinienne du tant décrié bisphénol A , substance chimique de synthèse utilisée depuis plus de 50 ans dans l'industrie du plastique. Elle a notamment adopté une proposition française en ce sens : celle...

Europe -
Applications pilot: dedicated support for small and medium-sized enterprises

EFSA has launched a new support initiative for applicants from small and medium-sized enterprises (SMEs). In the next six month, SMEs in the areas of feed additives and novel foods (excluding traditional food) can request an administrative check of their draft dossiers prior to submission. The support will be provided via teleconferences. The administrative check will ensure that draft dossiers from SMEs comply with the requirements specified in the regulatory framework before being submitted. The support applies only to the administrative aspects of an application. Scientific questions,...

France -
Compléments alimentaires et grossesse : l’Anses recommande d’éviter la multiplication des sources de vitamines et minéraux en l’absence de besoins établis

Dans le cadre du dispositif national de nutrivigilance, piloté par l’Anses, des signalements de cas d’hypercalcémie néonatale et d’hypothyroïdie congénitale impliquant des compléments alimentaires destinés aux femmes enceintes ont été rapportés. Ces signalements ont conduit l’Anses à évaluer les risques associés à la consommation de compléments alimentaires destinés aux femmes enceintes contenant de la vitamine D ou de l’iode. Dans l’avis publié ce jour, l’Agence met en garde contre la multiplication des sources de vitamines et minéraux, en l’absence de besoins établis. Elle attire...

Europe -
Public consultation: Guidance on the identity, characterisation and conditions of use of feed additives

EFSA has launched a public consultation on its draft guidance on the identity, characterisation and conditions of use of feed additives. The guidance document is intended to assist applicants in the preparation and presentation of an application for authorisation of a feed additive. It specifies what kind of information and data applicants need to include in the dossier to properly identify and characterise a feed additive. EFSA invites interested parties to submit written comments by 7 July 2017. Public consultation on the FEEDAP Panel’s guidance on the identity, characterisation and...

Europe -
Dietary reference values: EFSA publishes advice on vitamin K

EFSA has set dietary reference values for vitamin K as part of its review of scientific advice on nutrient intakes. The Panel on Dietetic Products, Nutrition and Allergies (NDA) decided to maintain the dietary reference values established by the Scientific Committee for Food in 1993. Consequently, the NDA Panel defined daily adequate intakes (AIs) for vitamin K as follows: 10 mg for infants aged 7-11 months. 12 mg for children aged 1-3 years. 20 mg for children aged 4-6. 30 mg for children aged 7-10. 45 mg for children aged 11-14. 65 mg for adolescents aged 15-17 and 70 mg for adults...

Europe -
New guidance: infant and follow-on formula from protein hydrolysates

New guidance published by EFSA will assist applicants in preparing and presenting dossiers for authorisation of infant and/or follow-on formulae manufactured from protein hydrolysates. It will also help applicants in preparing dossiers to assess a product’s efficacy in reducing the risk of infants becoming allergic to milk proteins...

Etude -
Les laits maternisés contenant des protéines hydrolysées dans la prévention des maladies allergiques et des allergies alimentaires

L’alimentation des nouveau-nés avec un lait maternisé contenant des protéines hydrolysées permet-elle de réduire le risque qu’ils développent des allergies (asthme, dermites ou eczéma, rhinite allergique) ou des allergies alimentaires pendant leur enfance ? ...

GET IN TOUCH

NEWSLETTER

Make sure you don't miss latest news, stay tuned!